Top Markets
Coin of the day
Microbix Biosystems Inc. Microbix Biosystems Inc.

Microbix Biosystems Inc.

MBX
株式のランク #28068
Microbix Biosystems Inc. is a life science enterprise dedicated to advancing... Microbix Biosystems Inc. is a life science enterprise dedicated to advancing human health globally, including markets across North America and Europe. Established in 1988 and headquartered in Mississauga, Canada, the company specializes in developing and marketing unique biological and technological products. A significant part of its business involves producing essential biological reagents for the diagnostic industry. This encompasses antigens vital for immunoassays, alongside its distinctive Quality Assessment and Proficiency (QAP) products. These QAPs are instrumental for clinical laboratories, providing support for proficiency testing, the development and validation of diagnostic assays, and optimizing routine lab operations. Furthermore, Microbix applies its deep biological knowledge and infrastructure to create additional proprietary offerings. Among these are DxTM, a viral transport medium crucial for stabilizing patient specimens prior to laboratory analysis, and Kinlytic Urokinase, a biopharmaceutical thrombolytic drug employed to treat blood clots. The company channels its QAP sales to accreditation organizations, diagnostic companies, and clinical laboratories via an extensive network of regional distributors.
株価
$0.20917201
最終同期: 2026-08-19
時価総額
$28.76M
変化(1日)
-1.72%
変化(1年)
23.48%
CA
取引 Microbix Biosystems Inc. (MBX)

カテゴリー

Microbix Biosystems Inc.(MBX)の発行済株式数
August 2026 時点の発行済株式数 0
Microbix Biosystems Inc. の最新の財務報告および株価によると、現在の発行済株式数は 0 です。August 2026 の終わりには、同社は 0 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Microbix Biosystems Inc.(MBX)の発行済株式数の履歴(2026 ~ 2026)
各年末時点の発行済株式数
発行済株式数 変化
提供された日付のデータは十分ではありません。
類似企業や競合他社の発行済株式数
企業 発行済株式数
253.90M -
US
396.00M -
US
62.19M -
NL
483.58M -
AU
- -
CH